论文部分内容阅读
目的探讨辛伐他汀对2型糖尿病血脂异常患者代谢指标的改善作用。方法选取2010年9月-2012年2月于本院进行治疗的52例2型糖尿病血脂异常患者为研究对象,将其随机分为对照组和观察组各26例,对照组进行常规治疗,观察组在其基础上加用辛伐他汀进行治疗,比较两组患者的治疗总有效率及治疗前后的血脂指标。结果观察组的治疗总有效率明显高于对照组,血脂指标改善幅度则大于对照组,P均<0.05,有显著性差异。结论辛伐他汀可有效改善2型糖尿病血脂异常患者的血脂水平,临床作用较为突出。
Objective To investigate the effect of simvastatin on metabolic indices in patients with type 2 diabetes with dyslipidemia. Methods Fifty-two patients with type 2 diabetes mellitus with dyslipidemia who were treated in our hospital from September 2010 to February 2012 were selected and randomly divided into control group and observation group, with 26 cases in each group. The control group was treated routinely and observed In addition, simvastatin was used to treat the patients. The total effective rate of the two groups was compared with that before and after treatment. Results The total effective rate of the observation group was significantly higher than that of the control group, while the improvement of the blood lipid level was greater than that of the control group (P <0.05). There was a significant difference. Conclusion Simvastatin can effectively improve the level of blood lipid in type 2 diabetic patients with dyslipidemia, the clinical effect is more prominent.